Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
AEON Biopharma, Inc. (AEON) had Return on Equity of -147.03% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$42.01M |
|
-- |
|
-- |
|
$-72.98M |
|
$72.98M |
|
$-30.98M |
|
$42.01M |
|
$42.01M |
|
$42.01M |
|
$42.01M |
|
$42.01M |
|
$42.01M |
|
$72.98M |
|
$73.08M |
|
0.54M |
|
0.58M |
|
$77.74 |
|
$72.93 |
|
| Balance Sheet Financials | |
$1.59M |
|
$0.23M |
|
$1.55M |
|
$3.14M |
|
$14.15M |
|
$11.69M |
|
$17.56M |
|
$31.71M |
|
$-28.57M |
|
$-28.57M |
|
$-28.57M |
|
0.56M |
|
| Cash Flow Statement Financials | |
$-20.29M |
|
-- |
|
$15.15M |
|
$5.16M |
|
$0.01M |
|
$-5.14M |
|
$6.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.69 |
|
-0.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-147.03% |
-147.03% |
|
1336.89% |
|
-248.84% |
|
$-51.38 |
|
$-35.23 |
|
$-35.23 |
|